Boston Scientific swings to $76M profit (AP via Yahoo! News)
Boston Scientific Corp. on Wednesday said it swung to a $76 million third-quarter profit from a big loss a year ago, narrowly beating Wall Street estimates after a string of disappointments since the medical device maker's $27 billion acquisition of Guidant Corp.

Gen-Probe Receives FDA Clearance to Run Standalone APTIMA(R) Tests for Chlamydia and Gonorrhea on the TIGRIS(R) System (PR Newswire via Yahoo! Finance)
Gen-Probe announced today that the U.S. Food and Drug Administration has granted marketing clearance to run the Company's standalone APTIMA assays for Chlamydia trachomatis and Neisseria gonorrhoeae on the high-throughput, fully automated TIGRIS system.